ArticleJournal for immunotherapy of cancer2020

Preconditioning of the tumor microenvironment with oncolytic reovirus converts CD3-bispecific antibody treatment into effective immunotherapy.

Christianne Groeneveldt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.